The objective of the graduate program is to prepare graduate and post graduate students to become proficient at evaluating the impact of pharmaceutical products, services, and programs, particularly in terms of their impact on patient outcomes. The program seeks to prepare students for leadership positions in outcomes research within academia, industry, and government.

Our students receive full financial support, including a competitive stipend, paid tuition, and health insurance. They complete the PhD program in approximately five years, and our graduates have taken postdocs in prestigious colleges (at Harvard and Duke, just to name a few) and found desirable positions in academia and in the pharmaceutical industry. We meet many of our students for the first time during the School's Recruitment Weekend each January.

• Graduate Student Information
  
• Graduate Students
• Graduates of the Program
  
  

• DPOP would like to congratulate Sharon Chen for graduating in December 2008. Sharon is now a senior outcomes scientist for Abt Bio-Pharma Solutions, Inc.
• DPOP would like to welcome our four new graduate students to the program: Jonas Daughtery, Christopher Gillette, Aaron Katz, and David Wei.
• DPOP would like to congratulate Hisham Aljadhey for graduating in August 2008.  Hisham is now an Assistant Professor of Clinical Pharmacy at the King Saudi University College of Pharmacy in Saudia Arabia.
• DPOP would like to congratulate Ashley Beard for successfully defending her dissertation “Cost as a Feature of Medical Management Communication in Medical Visits” on July 24th, 2008.  Ashley has accepted a position as Pharmaceutical Policy Research Fellow, Harvard Medical School, Department of Ambulatory Care and Prevention.

• Hisham Aljadhey: "The effects of NSAIDs on blood pressure, renal function, and serum potassium concentrations"
• Ashley Beard: "Cost as a feature medication management communication in medical visits"
• Shih-Yin (Sharon) Chen: "Second generation antidepressant use in treatment for major depressive disorder-an examination  of guideline components and healthcare utilization"

• Hisham Aljadhey: Assistant Professor of Clinical Pharmacy, Clinical Pharmacy Department, College of Pharmacy, King Saud University
• Ashley Beard: Pharmaceutical Policy Research Fellow, Harvard Medical School, Department of Ambulatory Care and Prevention
• Shih-Yin (Sharon) Chen: Senior Outcomes Scientist, Abt Bio-Pharma Solutions, Inc.